RYTM
RYTM
US76243J1051
Rhythm Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.23B EUR
7.64B EUR
5.95B EUR
7.19B EUR
Enterprise Value
6.07B EUR
7.58B EUR
5.89B EUR
7.14B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-171.79x
--
--
--
Price to Sales
25.95x
31.85x
27.41x
45.8x
Price to Book
60.68x
35.16x
25.05x
26.64x
EV/Revenue
25.28x
31.59x
27.14x
45.48x
EV/EBITDA
-30.39x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.1%
-1.39%
-2.02%
-1.06%
ende